Rapid changes of heteronuclear RNA for arginine vasopressin but not for corticotropin releasing hormone in response to acute corticosterone administration

Journal of Neuroendocrinology

Volumn 9, Issue 10, 1997, Pages 723-728

  Ma, Xin Ming ^a,b   Levy, Andrew ^a   Lightman, Stafford L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Adrenalectomy; Arginine vasopressin; Corticosterone; Corticotropin releasing hormone; Heteronuclear RNA

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; MESSENGER RNA; RNA;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HYPOTHALAMUS; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS; TIME;

EID: 0030767395     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1997.00646.x     Document Type: Article

References (31)

1. Whitnall MH. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 1993; 40: 573-629.
2. Albeck D, Hastings NB, McEwen BC. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on AVP and CRH mRNA in the rat hypothalamus. Mol Brain Res 1994; 26: 129-134.
3. Lightman SL, Young III WS. Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress. Proc Natl Acad Sci USA 1989; 86: 4306-4310.
4. Young III WS, Mezey E, Siegel RE. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci Lett 1986; 70: 231-241.
5. Jingami H, Matsukura S, Numa S, Imura H. Effects of adrenalectomy and dexamethasone administration on the level of preprocorticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin B-lipotropin processor mRNA in the pituitary in rats. Endocrinology 1985; 117: 1314-1320.
6. Beyer HS, Matta SG, Sharp BM. Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat. Endocrinology 1988; 123: 2117-2123.
7. Swanson LW, Simmons DM. Differential steroid hormone and neural influence on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemistry study in the rat. J Comp Neurol 1989; 285: 413-435.
8. Wolfson B, Manning RW, Davis LG, Arentzen R, Baldino F Jr. Co-localization of corticotropin-releasing factor and vasopressin mRNA in neurons after adrenalectomy. Nature 1985; 315: 59-61.
9. Davis LG, Arentzen R, Reid JM, Manning RW, Wolfson B, Lawrence KL, Baldino F Jr. Glucocorticoid sensitivity of vasopressin mRNA levels in the paraventricular nucleus of rat. Proc Natl Acad Sci USA 1986; 83: 1145-1149.
10. Young III WS, Mezey E, Siegel RE. Vasopressin and oxytocin mRNAs in adrenalectomized and Barttleboro rats: Analysis by quantitative in situ hybridization histochemistry. Mol Brain Res 1986; 1: 231-241.
11. Harbuz MS, Lightman SL. Glucocorticoid inhibition of stress-induced changes in hypothalamic corticotropin-releasing factor messenger RNA and proenkephalin A messenger RNA. Neuropeptides 1989; 14: 17-20.
12. Imaki T, Nahan J-L, Rivier C, Sawchenko PE, Vale W. Differential regulation of corticosterone-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J Neurosci 1991; 11: 585-599.
13. Makino S, Gold PW, Schulkin J. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis: comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Rex 1994; 657: 141-149.
14. Sawchenko PE. Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res 1987; 403: 213-224.
15. Kovacs K, Kiss JZ, Makara GB. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology 1986; 44: 229-234.
16. Ma X-M, Levy A, Lightman SL. Rapid changes in heteronuclear RNA for corticotropin-releasing hormone and arginine vasopressin in response to acute stress. J Endocrinol 1997; 152: 81-89.
17. Bartanusz V, Aubry J-M, Jezova D, Baffi J, Kiss JZ. Up-regulation of vasopressin mRNA in paraventricular hypophysiotrophic neurons after acute immobilization stress. Neuroendocrinology 1993; 58: 625-629.
18. Herman JP. In situ hybridization analysis of vasopressin gene transcription in the paraventricular and supraoptic nuclei of the rat: Regulation by stress and glucocorticoids. J Comp Neurol 1995; 363: 15-27.
19. Imaki T, Wang X-Q, Shibasaki T, Yamada K, Harada S, Chikada N, Naruse M, Demura H. Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoid in rats. J Clin Invest 1995; 96: 231-238.
20. Herman JP, Schafer MKH, Thompson RC, Watson SJ. Rapid regulation of corticotropin-releasing hormone gene transcription in vivo. Mol Endocrinol 1992; 6: 1061-1069.
21. Chowdrey HS, Larsen PJ, Harbuz MS, Jessop DS, Aguilera G, Eckland DJ, Lightman SL. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Br J Pharmacol 1995; 116: 2417-2424.
22. Lightman SL, Young III WS. Vasopressin, oxytocin, dynorphin, Enkephalin and corticotropin-releasing factor mRNA stimulation in the rat. J Physiol 1987; 394: 23-39.
23. Romero LM, Sapolsky RM. Patterns of ACTH secretagog secretion in response to psychological stimuli. J Neuroendocrinol 1996; 8: 243-258.
24. Kovács KJ, Sawchenko PE. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J Neurosci 1996; 16: 262-273.
25. Autelitano DJ, Blum M, Roberts JL. Changes in rat pituitary nuclear and cytoplasm pro-opiomelanocortin RNAs associated with adrenalectomy and glucocorticoid replacement. Mol Cell Endocrinol 1989; 66: 171-180.
26. Stauber C, Altschneid J, Akerblom IE, Marron JL, Mellon PL. Mutual cross-interference between glucocorticoid receptor and CREB inhibits transactivation in placental cells. New Biol 1990; 4: 527-540.
27. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M. Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990; 62: 1205-1215.
28. Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM. Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 1990; 62: 1217-1226.
29. Harbuz MS, Lightman SL. Response of hypothalamus and pituitary mRNA to physiological stress in the rat. J Endocrinol 1988; 122: 705-711.
30. Bartanusz V, Jezova D, Bertini LT, Tilders FJH, Aubry JM, Kiss JZ. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 1993; 132: 895-902.
31. Harbuz MS, Jessop DS, Lightman SL, Chowdrey HS. The effects of restraint or hypertonic saline on corticotrophin-releasing factor, arginine vasopressin, and proenkephalin A mRNAs in the CYF, Sprague-Dawley and Wistar strains of rat. Brain Res 1994; 667: 1-12.